PMC:7204657 / 13-184 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"22","span":{"begin":137,"end":141},"obj":"Gene"},{"id":"26","span":{"begin":106,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:C000657245"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Gene:3569"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:C502936"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":31,"end":41},"obj":"Body_part"},{"id":"T2","span":{"begin":151,"end":159},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma7199"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":2,"end":10},"obj":"Disease"},{"id":"T2","span":{"begin":31,"end":53},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0006807"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":31,"end":41},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T2","span":{"begin":31,"end":41},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"},{"id":"T3","span":{"begin":119,"end":120},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":106,"end":117},"obj":"Chemical"},{"id":"T2","span":{"begin":137,"end":139},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A3","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-sentences","denotations":[{"id":"T2","span":{"begin":12,"end":53},"obj":"Sentence"},{"id":"T3","span":{"begin":55,"end":67},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":31,"end":53},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0031368"}],"text":"n COVID-19: Beware the risk of intestinal perforation\n\nDear Editor,\nZhang et al. [1] discussed the use of tocilizumab, a monoclonal anti-IL-6 receptor antibody, in the tre"}